Artificial Intelligence Use for the Detection of Atrial Fibrillation Drivers (AI Fib)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03401931
Recruitment Status :
(another design of protocole is submitted for approuval before the start date)
First Posted : January 17, 2018
Last Update Posted : April 28, 2020
Hospital St. Joseph, Marseille, France
Information provided by (Responsible Party):
SEITZ JULIEN, Hospital St. Joseph, Marseille, France
pilot clinical study, multicenter, prospective, open, nonrandomized
Condition or disease
Fibrillation, AtrialTo Evaluate the Intraoperative Efficiency of the AIFIB Software in the Detection of Atrial Fibrillation Driver During an Ablation Procedure
The hypothesis is that ablation targeting PVI alone for the treatment of persistent AF is less efficient that ablation targeting electrophysiologic areas with spatio-temporal-dispersion with or without PVI
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
major patient with an indication of AF or AT ablation
Inclusion Criteria: major patient with an indication of AF or AT ablation -